TickerFiles

Biofrontera Inc. 10-K filing

Filed 2026-03-19 · Report date 2025-12-31 · 2025 FY

View Original SEC Filing

Filing metadata

Accession number
0001493152-26-011625
Form type
10-K
CIK
0001858685
Primary document
https://www.sec.gov/Archives/edgar/data/1858685/000149315226011625/form10-k.htm

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for Biofrontera Inc..

Reported financial metrics

MetricCurrentPriorChange
Revenue$41.7M--
Operating Income$-11.3M--
Net Income$-10.5M--
Eps Basic-1.04--
Eps Diluted-1.04--
Cash And Equivalents$6.4M--
Total Assets$28.6M--
Total Liabilities$18.1M--
Shareholders Equity$10.5M--
Operating Cash Flow$-13.4M--
Capital Expenditures$2,000--